 |
 |

Aminophylline in the Treatment of Acute Asthma When β2-Adrenergics and Steroids Are Provided
Daniel G. Murphy, MD;
Michael F. McDermott, MD;
Robert J. Rydman, PhD;
Edward P. Sloan, MD;
Robert J. Zalenski, MD
Arch Intern Med. 1993;153(15):1784-1788.
Abstract
 |  |
Background The purpose of this study was to test the contribution of aminophylline in improving peak expiratory flow rate (PEFR) during emergency department treatment of acute asthma when metaproterenol sulfate and steroid therapy are also provided.
Methods In a prospective, randomized, double-blind, and placebo-controlled trial at a municipal hospital emergency department, 44 patients with acute asthma, aged 18 to 45 years, with theophylline levels below 28 µmol/L, who had failed to achieve a PEFR of 40% predicted after one nebulized metaproterenol treatment, were recruited. An aminophylline or placebo loading dose and maintenance infusion were administered. All patients received hourly nebulized metaproterenol and initial methylprednisolone sodium succinate. The PEFR was measured hourly for 5 hours. Two-factor repeated-measures analysis of variance of improvement in PEFR ([final—initial PEFR]/predicted PEFR) was assessed.
Results There was no difference in improvement of PEFR at any hour between the treatment and placebo groups. After 5 hours, the difference in improvement ratio was 0.40 (aminophylline) vs 0.36 (placebo) (P=.30; n=22 in each group). The treatment group suffered more tremor, nausea or vomiting, and palpitations (P<.05).
Conclusion In the emergency department setting, aminophylline contributes no significant improvement in PEFR when β2-agonists and corticosteroids are being provided, while causing more side effects.
(Arch Intern Med. 1993;153:1784-1788)
Author Affiliations
From the Department of Emergency Medicine, Cook County Hospital (Drs Murphy, McDermott, Rydman, and Zalenski), the University of Illinois School of Public Health (Drs Murphy, Rydman, and Zalenski), and the Program in Emergency Medicine, University of Illinois College of Medicine (Drs Rydman and Sloan), Chicago.
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
Efficacy of IV Theophylline in Children With Severe Status Asthmaticus
Ream et al.
Chest 2001;119:1480-1488.
ABSTRACT
| FULL TEXT
Evidence-based guideline on the primary care management of asthma
Eccles et al.
Fam Pract 2001;18:223-229.
FULL TEXT
Should aminophylline be abandoned in the treatment of acute asthma in adults?
Hart
QJM 2000;93:761-765.
ABSTRACT
| FULL TEXT
Randomised controlled trial of aminophylline for severe acute asthma
Yung and South
Arch. Dis. Child. 1998;79:405-410.
ABSTRACT
| FULL TEXT
Similarities and discrepancies between exacerbations of asthma and chronic obstructive pulmonary disease
Fabbri et al.
Thorax 1998;53:803-808.
FULL TEXT
Standards of laboratory practice: theophylline and caffeine monitoring
Pesce et al.
Clin. Chem. 1998;44:1124-1128.
ABSTRACT
| FULL TEXT
Alternatives to Standard Status Asthmaticus Therapy
Everett
Journal of Pharmacy Practice 1997;10:186-199.
ABSTRACT
Theophylline in Asthma
Weinberger and Hendeles
NEJM 1996;334:1380-1388.
FULL TEXT
North of England evidence based guidelines development project: summary version of evidence based guideline for the primary care management of asthma in adults
BMJ 1996;312:762-766.
FULL TEXT
AMINOPHYLLINE ADDS LITTLE TO ACUTE ASTHMA TREATMENT
JWatch General 1993;1993:3-3.
FULL TEXT
|